American Journal of Epidemiology Vol. 94, No. 2: 166-171
Copyright © 1971 by The Johns Hopkins University School of Hygiene and Public Health
other |
CHARACTERIZATION OF FOUR NEW ADENOVIRUS SEROTYPES ISOLATED FROM CHIMPANZEE TISSUE EXPLANTS
1National Institute of Neurological Diseases and Stroke, National Institutes of Health Bethesda, Maryland 20014
Basnight, M., Jr. (NINDS, NIH, Bethesda, Md. 20014), N. G. Rogers, C. J. Gibbs, Jr. and D. C. Gajdusek. haracterization of four new adenovirus serotypes isolated from chimpanzee tissue explants. Amer J Epidem 94: 166–171, 1971.—Four new latent adenovirus serotypes were isolated from explanted lymph nodes of chimpanzees in the late stages of experimental kuru and Creutzfeldt-Jakob disease. These viruses induced typical adenovirus cytopathology in human embryonic kidney cell cultures and fixed complement in the presence of human adenovirus antiserum. They had the biochemical and physical characteristics of adenoviruses; they propagated better in cell cultures of human than in those of simian origin. They were not neutralized by antisera of known human and simian adenovirus types and were immunologically distinct from each other. The viruses are not believed to be the agents of the experimental kuru or Creutzfeldt-Jakob disease in the chimpanzees from which they were isolated, although these animals developed homologous neutralizing antibodies during the course of their disease. Neutralizing antibodies to these new adenovirus serotypes were also found in normal chimpanzees, but were absent from sera of animal handlers who had been in close contact with the chimpanzees for 1–3 years.
adenovirus; cell culture, prolonged; tissue cultures explanted; viruses, chimpanzee
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Hashimoto, J. L. Boyer, N. R. Hackett, J. M. Wilson, and R. G. Crystal Induction of Protective Immunity to Anthrax Lethal Toxin with a Nonhuman Primate Adenovirus-Based Vaccine in the Presence of Preexisting Anti-Human Adenovirus Immunity Infect. Immun., October 1, 2005; 73(10): 6885 - 6891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Purkayastha, S. E. Ditty, J. Su, J. McGraw, T. L. Hadfield, C. Tibbetts, and D. Seto Genomic and Bioinformatics Analysis of HAdV-4, a Human Adenovirus Causing Acute Respiratory Disease: Implications for Gene Therapy and Vaccine Vector Development J. Virol., February 15, 2005; 79(4): 2559 - 2572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Reyes-Sandoval, J. C. Fitzgerald, R. Grant, S. Roy, Z. Q. Xiang, Y. Li, G. P. Gao, J. M. Wilson, and H. C. J. Ertl Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes J. Virol., July 15, 2004; 78(14): 7392 - 7399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Fitzgerald, G.-P. Gao, A. Reyes-Sandoval, G. N. Pavlakis, Z. Q. Xiang, A. P. Wlazlo, W. Giles-Davis, J. M. Wilson, and H. C. J. Ertl A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag J. Immunol., February 1, 2003; 170(3): 1416 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Xiang, G. Gao, A. Reyes-Sandoval, C. J. Cohen, Y. Li, J. M. Bergelson, J. M. Wilson, and H. C. J. Ertl Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product J. Virol., February 22, 2002; 76(6): 2667 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Cohen, Z. Q. Xiang, G.-P. Gao, H. C. J. Ertl, J. M. Wilson, and J. M. Bergelson Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor J. Gen. Virol., January 1, 2002; 83(1): 151 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Farina, G.-p. Gao, Z. Q. Xiang, J. J. Rux, R. M. Burnett, M. R. Alvira, J. Marsh, H. C. J. Ertl, and J. M. Wilson Replication-Defective Vector Based on a Chimpanzee Adenovirus J. Virol., December 1, 2001; 75(23): 11603 - 11613. [Abstract] [Full Text]
|
|